Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 53 clinical trials
A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

The purpose of this study is to evaluate MEDI5752 in combination with axitinib.in subjects with advanced renal cell carcinoma.

  • 5 views
  • 17 Jan, 2021
  • 17 locations
Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

The investigators reported previously that epigenetic activation of organic cation transporter (OCT2) by decitabine sensitizes RCC cells to oxaliplatin both in vitro and in xenografts. The objective of this phase II clinical trial is to investigate the efficacy and safety of sequential combination therapy with decitabine and oxaliplatin in patients …

myocardial infarction
cancer
oxaliplatin
platelet count
neutrophil count
  • 1 views
  • 11 Aug, 2019
Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma

To determine if Carevive software, which monitors treatment-related toxicities and then generates self-care management plans for these symptoms, will be feasible to implement among patients with metastatic renal cell carcinoma (RCC). Additionally for collection of preliminary data on treatment-related toxicities, quality of life, distress level, and drug adherence.

  • 1 views
  • 19 Jan, 2021
  • 1 location
Combined Alternating Sunitinib and Bevacizumab (Avastin ) in Advanced Renal Cell Carcinoma (CASA)

Combined sunitinib and bevacizumab in advanced renal cell carcinoma.

bevacizumab
carcinoma
renal function tests
brain metastases
metastasis
  • 39 views
  • 08 Nov, 2020
  • 1 location
Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma

in vitro transcribed (IVT) RNA from an autologous tumor specimen and CD40L RNA. CMN-001 is indicated for treatment of intermediate/poor risk patients with advanced renal cell carcinoma (RCC) in

  • 0 views
  • 30 Sep, 2020
  • 82 views
  • 16 Jan, 2021
  • 12 locations
Study of the Combination of CM082 With Everolimus in Patients With mRCC

Advanced Renal Cell Carcinoma.

everolimus
cancer therapy
cancer
measurable disease
endocrine therapy
  • 0 views
  • 08 Nov, 2020
  • 1 location
CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma

This randomized, double blind, phase 2/3 study is aimed to evaluate the efficacy and safety of CM082 in combination with everolimus in Chinese patients with advanced renal cell carcinoma. The

  • 17 views
  • 08 Nov, 2020
  • 1 location
Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma

TITAN RCC (0216-ASG) is a Phase 2, open-label study of nivolumab monotherapy with additional nivolumab/ipilimumab "boost" cycles in previously untreated and pretreated (2nd line), advanced or metastatic renal cell carcinoma (mRCC) subjects with intermediate and high risk disease according to IMDC.

carcinoma
metastasis
nivolumab
ipilimumab
nephrectomy
  • 916 views
  • 08 Nov, 2020
  • 3 locations